MaxCyte Grants 375,000 Options and 187,500 RSUs to New CFO
MaxCyte granted inducement awards of 375,000 stock options at a $0.676 exercise price and ten-year term, plus 187,500 RSUs, to CFO Parmeet Ahuja. The options vest 25% after one year and monthly over three years, while RSUs vest 25% after one year and in three equal annual installments.
1. Inducement Awards to CFO
MaxCyte’s Compensation Committee approved inducement grants of 375,000 stock options and 187,500 restricted stock units to Parmeet Ahuja in conjunction with his appointment as Chief Financial Officer under the 2026 Inducement Plan.
2. Vesting Terms and Conditions
The stock options carry a $0.676 exercise price, ten-year term, and vest 25% after one year with the remainder vesting monthly over 36 months; RSUs vest 25% after one year and in three equal annual installments, contingent on continuous service.